PYXS – pyxis oncology, inc. (US:NASDAQ)
Stock Stats
News
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum [Yahoo! Finance]
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock.
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Form SCHEDULE 13D/A Pyxis Oncology, Inc. Filed by: Sullivan Lara
Form 4 Pyxis Oncology, Inc. For: Mar 31 Filed by: Sullivan Lara
Form 4 Pyxis Oncology, Inc. For: Mar 31 Filed by: Metzger Michael A
Form 4 Pyxis Oncology, Inc. For: Mar 31 Filed by: Wadhane Jitendra
Form 4 Pyxis Oncology, Inc. For: Mar 31 Filed by: HUMPHREY RACHEL
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.